OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein contributions to brain atrophy acceleration in Alzheimer’s disease and primary age-related tauopathy
Keith A. Josephs, Peter R. Martin, Stephen D. Weigand, et al.
Brain (2020) Vol. 143, Iss. 11, pp. 3463-3476
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Structural progression of Alzheimer’s disease over decades: the MRI staging scheme
Vincent Planche, José V. Manjón, Boris Mansencal, et al.
Brain Communications (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 82

Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 82

Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 26

Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease
Ana Rita Agra de Almeida Quadros, Zhaozhi Li, Xue Wang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 23

Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Janusz Błasiak, Piotr Sobczuk, Elżbieta Pawłowska, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101735-101735
Open Access | Times Cited: 43

Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
Nick Corriveau‐Lecavalier, Hugo Botha, Jonathan Graff‐Radford, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 14

Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
Laura Wisse, Anika Wuestefeld, Melissa Murray, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1

Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease
Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 757
Open Access | Times Cited: 7

Circulating extracellular vesicles: friends and foes in neurodegeneration
Riccardo Calvani, Anna Picca, Flora Guerra, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 534-534
Open Access | Times Cited: 35

TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
Caitlin S. Latimer, Jade G. Stair, Joshua C. Hincks, et al.
Disease Models & Mechanisms (2022) Vol. 15, Iss. 4
Open Access | Times Cited: 28

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
Sheelakumari Raghavan, Scott A. Przybelski, Robert I. Reid, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 27

Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology
Shefali Chaudhary, Simon Zhornitsky, Herta H. Chao, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2022) Vol. 37
Open Access | Times Cited: 26

Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Yuichi Riku, Yasushi Iwasaki, Shinsuke Ishigaki, et al.
Brain (2022) Vol. 145, Iss. 8, pp. 2769-2784
Open Access | Times Cited: 24

TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Yuichi Riku, Mari Yoshida, Yasushi Iwasaki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15755-15755
Open Access | Times Cited: 24

Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders—Denial is not an option
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Glen Greenough, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 15

Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults
Bernard Hanseeuw, Heidi I.L. Jacobs, Aaron P. Schultz, et al.
Neurology (2023) Vol. 101, Iss. 24
Closed Access | Times Cited: 15

Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
Vincent Planche, Boris Mansencal, José V. Manjón, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 5

Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years
Keith A. Josephs, Stephen D. Weigand, Jennifer L. Whitwell
Neurology (2022) Vol. 98, Iss. 22
Open Access | Times Cited: 21

Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease
Kathryn Gauthreaux, Charles Mock, Merilee Teylan, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 12, pp. 975-987
Open Access | Times Cited: 19

Microstructural alterations in the locus coeruleus‐entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia
Giulia Quattrini, Lorenzo Pini, Ilaria Boscolo Galazzo, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Atypical clinical variants of Alzheimer’s disease: are they really atypical?
Jennifer L. Whitwell
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4

Unraveling metabolic alterations in transgenic mouse model of Alzheimer's disease using MALDI MS imaging with 4-aminocinnoline-3-carboxamide matrix
Yanwen Chen, Dejun Hu, Lisha Zhao, et al.
Analytica Chimica Acta (2021) Vol. 1192, pp. 339337-339337
Closed Access | Times Cited: 24

TDP‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy
Denis S. Smirnov, David P. Salmon, Douglas Galasko, et al.
Annals of Neurology (2022) Vol. 92, Iss. 3, pp. 425-438
Open Access | Times Cited: 17

White matter hyperintensities and TDP‐43 pathology in Alzheimer's disease
Arenn F. Carlos, Stephen D. Weigand, Nha Trang Thu Pham, et al.
Alzheimer s & Dementia (2025)
Open Access

Page 1 - Next Page

Scroll to top